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A B S T R A C T
Staphylococcal food poisoning – caused by certain enterotoxigenic staphylococci – is one of the most common
worldwide foodborne diseases. In this context, bacterial biofilms on food processing plan surfaces can represent
critical sources of contamination, being more resistant to cleaning and disinfection procedures. Therefore, it is
important to prevent and control biofilm formation in food facilities. In the last years, antimicrobial peptides
(AMPs) have emerged as promising biofilm contrasting tools. The recently developed AMP, named 1018-K6,
revealed a significant bactericidal (MBC 10 μM) and biofilm-preventing efficiency (MBIC 50 μM) against a re-
ference ATCC strain of Listeria monocytogenes and remarkable stability under different environmental conditions.
In this work, a kinetic of action of 1018-K6 against two strong biofilm-producing reference strains of
Staphylococcus aureus (including a methicillin-resistant S. aureus strain) and a moderate biofilm producer en-
terotoxigenic S. aureus isolated from cheese, was performed. The peptide showed an impressive rapid mode of
action, eradicating established biofilms within few minutes. Bactericidal activity against planktonic cells and
inhibition of biofilm formation were also observed. The significant properties of 1018-K6 make it a promising
candidate for applications in food-safety and quality control.
1. Introduction
Food safety is a global concern with significant implications for
human health. It has been estimated from world health organization
that at least 600 million people worldwide are subject annually to ill-
nesses caused by unsafe food (World Health Organization, 2015).
Staphylococcus aureus is a commensal and opportunistic pathogen
that can cause contamination of food products during preparation and
processing (Grace & Fetsch, 2018). It is a ubiquitous microorganism
occurring on the skin and the mucous membrane of many warm-
blooded animals, including human. For these reasons, food handlers are
frequently implicated in transmission of such bacteria to food
(Gutiérrez et al., 2012). S. aureus displays a high salt tolerance, so it can
grow in ham and other meats and in dairy products. Although heat-
treatment (e.g., cooking) easily kills S. aureus bacteria, some strains are
able to produce enterotoxins that are resistant to heat, freezing and
irradiation (Hennekinne, De Buyser, & Dragacci, 2012). Detectable le-
vels of the staphylococcal enterotoxins (SEs) are produced when the
enterotoxigenic strain grows to levels> 105 CFU/g, and their presence
in food is responsible for the staphylococcal food poisoning (SFP), one
of the most common foodborne diseases worldwide (Hennekinne,
2018). SFP symptoms usually develop within 30min to 6 h, and gen-
erally include vomiting, nausea, stomach cramps, and diarrhea
(Hennekinne, 2018).
The customer's awareness about chemical compounds used to con-
trast the growth of spoiling and pathogenic microorganisms, led to an
increasing demand for natural preservatives. In this scenario, anti-
microbial peptides (AMPs) are assuming remarkable interest because of
their properties and natural origin (Keymanesh, Soltani, & Sardari,
2009). AMPs are components of the innate immune system of both
prokaryotes and eukaryotes, and they are usually characterized by a
broad antimicrobial spectrum activity, a low propensity for developing
bacterial resistance, and a significant synergy with common anti-
microbials (Palmieri et al., 2016, 2018; Wang, Zeng, Yang, & Qiao,
2016). The activity of AMPs is related to their physicochemical prop-
erties, e.g. amphiphilicity, net charge, hydrophobicity, and conforma-
tional flexibility (Bechinger & Gorr, 2017).
Innate defense regulator peptide-1018 (IDR-1018) is a 12-mer
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cationic peptide (VRLIVAVRIWRR-NH2), deriving from the bovine
host-defense peptide (HDP) bactenecin, found in the bovine neutrophil
granules and belonged to the cathelicidin's family. IDR-1018, which has
been developed by Mansour and colleagues (Mansour, de la Fuente-
Núñez, & Hancock, 2015), displays a broad-spectrum anti-biofilm ac-
tivity versus Gram-negative and Gram-positive bacterial pathogens in-
cluding Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus
and Salmonella Typhimurium (de la Fuente-Núñez et al., 2012; de la
Fuente-Núñez, Reffuveille, Haney, Straus, & Hancock, 2014;
Reffuveille, de la Fuente-Núñez, Mansour, & Hancock, 2014).
Recently, a new 1018-derivative antimicrobial peptide named 1018-
K6, in which the alanine in position 6 was replaced with a lysine re-
sidue, was designed (Palmieri et al., 2018). This single point mutation
was revealed to have a strong impact on the conformational status of
1018-K6, inducing an increased propensity to assume α-helix structures
in membrane-mimetic models such as micellar solutions of SDS, dif-
ferently from the parent IDR-1018, characterized by a predominant β-
sheet structure (Palmieri et al., 2018). Furthermore, 1018-K6 was able
to retain its structural integrity better than IDR-1018 in a wide range of
pH and temperature conditions for prolonged incubation times showing
also a significant bactericidal and biofilm preventing activity specifi-
cally against Listeria monocytogenes isolates from food-products and
food-processing environments (Palmieri et al., 2018).
The present study was aimed at evaluating the antimicrobial and
anti-biofilm activity of 1018-K6 on planktonic and biofilm growth of
two reference and one food-isolate strains of S. aureus in order to assess
the potential use and effectiveness of this peptide in the struggle against
such critical foodborne pathogen able to cause diverse life-threatening
infections.
2. Materials and methods
2.1. Materials
Two reference strains from ATCC collection were used in this study:
the methicillin-sensitive Staphylococcus aureus (MSSA) ATCC 35556, a
well-known strong biofilm producer on polystyrene (Di Ciccio et al.,
2015; Thompson, Abraham, & Jefferson, 2010), and the methicillin-
resistant Staphylococcus aureus (MRSA) ATCC 33591, also described as a
strongly adherent strain (Gowrishankar, Kamaladevi, Balamurugan, &
Pandian, 2016). Furthermore, a S. aureus strain isolated from cheese
(SA1) carrying four SEs genes (sea, sed, sej, and ser) was also included in
this study.
All culture media were purchased from Oxoid (Milan, Italy) unless
otherwise specified. Phosphate buffered saline (PBS) was used for
washing and rinsing bacteria. The derivative 12-mer peptide 1018-K6,
reproducing the IDR-1018 sequence with the replacement of the ala-
nine in position 6 with a lysine residue (A6→K6 mutation) (Palmieri
et al., 2018), was purchased from SynPeptide Co., LTD (Shanghai,
China).
3. Methods
3.1. Antibacterial activity assay
The Minimum Inhibitory Concentration (MIC) and the Minimum
Bactericidal Concentration (MBC) were determined by the standard
broth microdilution method following recommendations of the Clinical
& Laboratory Standards Institute (CLSI, 2015). Briefly, tested bacteria
cultures were cultured on Tryptic Soy Agar (TSA) at 37 °C for 24 h.
Isolated colonies were inoculated in Tryptic Soy Broth (TSB), growth for
16 h at 37 °C and diluted to 5×105 CFU/mL (CFU, colony forming
units) in Muller Hinton II broth (MHB-II; Liofilchem, Italy). The bac-
teria were treated with 1018-K6 (ranging from 0.156 to 80 μM) in
100 μL culture medium (MHB-II) for 16 h at 37 °C. The cell growth was
measured by the absorbance at 620 nm in a microplate reader (Victor,
PerkinElmer, Waltham, MA). The MIC is defined as the lowest con-
centration of the peptide at which no bacterial growth was detected. To
determine the MBC, 50 μL of the bacterial cell suspension was taken
based on the MICs and cultivated on a Tryptic Soy Agar (TSA) plates.
The bacterial cells were enumerated after incubation at 37 °C for
24–48 h. MBCs is defined as the lowest concentration of peptide at
which more than 99.9% of the bacterial cells are killed. At least six
technical replicates were included for each group, and all experiments
were performed in triplicate.
3.2. Inhibition of biofilm formation
The ability of 1018-K6 to prevent biofilm formation was evaluated
in 96-wells flat bottom polystyrene microtiter plates (SPL Life Sciences,
Korea). Biofilms were allowed to form in absence or in presence of
1018-K6, according to a previously described method (Stepanović et al.,
2007), with slight modifications. Briefly, 200 μL of S. aureus ATCC
35556, MRSA ATCC 33591, or SA1 bacterial cultures, serially diluted to
5×106 CFU/mL in TSB, were distributed in each well of the microtiter
plates and the peptide was added in order to reach the concentration of
80 μM. Plates were incubated at 37 °C for 24 h. After incubation, the
supernatant was discarded and each well was washed three times with
300 μL of sterile PBS. The remaining bacteria were heat-fixed (60 °C,
60min) and stained with 150 μL of 2% crystal violet (Conda labora-
tories, Madrid, Spain) for 20min. After staining, bacteria were rinsed
under running tap water. Therefore, the microplate was air dried at
room temperature, and the dye bound to the cells was resolubilized
with 150 μL of 95% ethanol (Carlo Erba reagents, Milan, Italy) per well.
The optical density (OD) of each well stained with crystal violet was
measured at 540 nm using a microtiter-plate reader (Victor, Perki-
nElmer, Waltham, MA). At least six technical replicates were included
for each group, and all experiments were performed in triplicate. Ac-
cording to the OD values of negative controls, the cutoff value (ODc)
was established as follow: ODmean + 3 * St. deviation. The OD value of
a tested condition (control, 1018-K6 treated) is expressed as OD mean
value of the condition reduced by ODc value.
3.3. Minimum biofilm eradication concentration determination
Minimum biofilm eradication concentration (MBEC) assay was used
to test susceptibility of the pre-formed S. aureus ATCC 35556, MRSA
ATCC 33951, or SA1 biofilms to 1018-K6 (Ceri et al., 2001). Briefly,
150 μL of bacterial cultures diluted to 105 CFU/mL were added to the
wells of 96-wells flat-bottom microtiter plates (Nunc, Roskilde, Den-
mark). Then, plates were covered with a 96-peg lid (Immuno TSP lids;
Nunc, Roskilde, Denmark), sealed with Parafilm®, and placed on an
microtiter shaker (MTS 2/4 digital microtiter shaker, IKA-Works,
Staufen im Breisgau, Germany), set to 150 revolutions per min (rpm), in
a humidified atmosphere (40%) at 37 °C (G-Cell 115, Fratelli Galli,
Milan, Italy) for 24 h, to allow biofilm formation on the pegs under
batch conditions. Subsequently, planktonic bacteria were removed by
rinsing the peg lid in 200 μL of sterile PBS. Biofilms on the pegs were
exposed to 1018-K6 (0.25–80 μM) in 200 μL PBS for 24 h at 37 °C. After
exposure, the peg lid was rinsed, as described previously, for 1min, and
then transferred to a new microtiter plate containing 200 μL/well of
fresh TSB and sonicated for 15min (Ultrasonik 57H; NEY, USA), in
order to disperse the cells from the peg surface (recovery plate). After
sonication, an aliquot (50 μL) was used for preparing serial dilutions
that were spot plated (20 μL) on TSA. The peg lid was then discarded
and the recovery plate was covered with a normal lid and incubated for
24 h at 37 °C. The MBEC is defined as the lowest concentration of 1018-
K6 required to eradicate the biofilm of a selected isolate after a recovery
period of 24 h at 37 °C. At least four technical replicates were included
for each group, and all experiments were performed in triplicate.
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3.4. Biofilm eradication assay
Biofilm eradication was assayed using the previously described
protocol. Briefly, 150 μL inoculum of S. aureus ATCC 35556, MRSA
ATCC 33591, and SA1 were prepared at 105 CFU/ml concentration.
Biofilms were grown for 24 h at 37 °C, 150 rpm, on TSP peg lid. Then,
cells were exposed to 1018-K6 (80 μM) at different times of contact
ranging from 1min to 48 h at 37 °C. Cells were recovered in fresh TSB
by sonication at room temperature for 15min. An aliquot from each
well was spot plated on TSA, then the microtiter plate was incubated at
37 °C for 24 h. Following incubation, OD was detected using a micro-
titer-plate reader (Victor, PerkinElmer, Waltham, MA). Cells spot plated
were counted after 24 h incubation at 37 °C. Log10 CFU/peg was cal-
culated as follow: Log10 [(X∙B−1) (D)+1], where X is CFU counted on
spot plate, B is the volume plated, and D is the dilution. At least six
technical replicates were included for each group, and all experiments
were performed in triplicate.
3.5. Circular dichroism spectroscopy
The secondary structure of the peptides was investigated by circular
dichroism spectroscopy (CD) using a Jasco J-810 spectropolarimeter
(Tokyo, Japan). The peptide samples at different concentrations (40, 60
and 80 μM in PBS) were loaded into a quartz cuvette of 0.1 cm path
length (Hellma Analytics, Milan, Italy) and the spectra were recorded at
25 °C in the 190 nm–260 nm range at 20 nm/min scanning speed, by
averaging 5 scans and in presence of 3mM SDS as membrane-mi-
micking environment. To analyze the circular dichroism spectra ob-
tained under the different experimental conditions, the relative con-
tribution of three secondary structure elements (α-helix, β-structure
and random coil) to the overall structure of the peptide was estimated
by the DICHROWEB site (Lobley, Whitmore, & Wallace, 2002;
Whitmore & Wallace, 2004, 2008), using the CDSSTR algorithm
(Sreerama & Woody, 2000; van Stokkum, Spoelder, Bloemendal, van
Grondelle, & Groen, 1990) and the BeStSel (Beta Structure Selection)
web server, which is freely accessible at http://bestsel.elte.hu/index.
php (Micsonai et al., 2018).
3.6. Scanning electron microscopy
Three-dimensional architecture of S. aureus ATCC 35556 biofilms
exposed to 1018-K6 was studied by using the scanning electron mi-
croscope (SEM). Biofilms were grown for 24 h and then exposed to
1018-K6 (80 μM), as previously described, for 16 h at 37 °C. Pegs were
removed from TSP lid using a flamed sterilized blade, and cells were
fixed with 2.5% glutaraldehyde (Polysciences Inc., Warrington, PA,
USA) in PBS at 4 °C for 16 h. Samples were washed three times with PBS
(5min each) and dehydrated at room temperature through a series of
alcohol (50%–99% ethanol; Carlo Erba reagents, Milan, Italy). Samples
were left to dry in a fume hood for 72 h, then were sputter-coated with a
gold-palladium layer using a SCD 040 coating device (Balzer Union,
Liechtenstein). Samples were observed using a Zeiss DSM 950 scanning
electron microscope at an accelerating voltage of 10 kV (Zeiss,
Oberkochen, Germany). The images were processed for display using
Photoshop (Adobe Systems Inc., San Jose, CA).
3.7. Statistical analysis
Statistical analyses were carried out using GraphPad Prism version
7.04 for Windows (GraphPad Software, La Jolla California USA, www.
graphpad.com). Rate of biofilm inhibition (OD540nm mean) for each
strain were examined using unpaired t-test. Rate of biofilm eradication
(biofilm viable count (Log10 CFU/peg) at each time point) for each
strain were examined using a Kruskall–Wallis test, with a Dunn's post-
hoc test used to identify individual differences relative to the untreated
control (PBS) for each strain at each time point. In all cases, significance
was denoted with a probability of p < 0.05.
4. Results and discussion
4.1. Antimicrobial activity of 1018-K6 on planktonic S. aureus cells
The MIC values of 1018-K6 against planktonic S. aureus strains were
first determined. Overall, 1018-K6 managed to inhibit the growth of the
two reference S. aureus strains, MSSA ATCC 35556 and MRSA ATCC
33591, as well as that of the wild SA1 strain, with MIC values of 20 μM.
To investigate further the bactericidal activity of the peptide, the MBC
was evaluated. Specifically, the MBC was found to be 20 μM, a value
that was on a par with the corresponding MIC, thus indicating that the
tested compound should be considered to have bactericidal mode of
action against S. aureus ATCC 35556, MRSA ATCC 33591 and SA1 cells.
In addition, a comparison between 1018-K6 and the parent peptide
IDR-1018 revealed that the MIC value of the AMP used in this study was
half the concentration required by IDR-1018 to completely inhibit the
growth of a MRSA strain (i.e., 40 μM), as reported by de la Fuente-
Núñez et al. (2014), showing an improvement in cell-inhibiting per-
formance of the modified peptide 1018-K6.
4.2. Evaluation of the activity of 1018-K6 against biofilm formation of S.
aureus
Considering the difficulty of treating contaminations associated
with staphylococcal biofilms, we decided to test the ability of 1018-K6
to prevent biofilm formation. To this aim, the three strains included in
this study were cultured in planktonic form in absence or presence of a
peptide concentration of 80 μM. As shown in Fig. 1, the biomass
quantification confirmed the strong capacity of the two reference
strains (MSSA ATCC 35556 and MRSA ATCC 33591) to produce bio-
film, as well as the moderate biofilm formation ability of the en-
terotoxigenic SA1. Interestingly, a striking ability of 1018-K6 to reduce
the biofilm biomass of all the S. aureus strains was observed compared
to control cells incubated in medium without 1018-K6 (unpaired t-test;
p < 0.0001). The peptide successfully inhibited biofilm formation in
each of these strains as confirmed by the OD values of the treated
Fig. 1. Inhibition of biofilm production of Staphylococcus aureus ATCC 35556
(MSSA), methicillin-resistant S. aureus ATCC 33591 (MRSA) and S. aureus SA1
strains by 1018-K6 [80 μM]. Average OD values are shown with error bars
representing standard deviation. *** indicates significant difference
(p < 0.001) between the treated and the control samples. **** indicates sig-
nificant difference (p < 0.0001) between the treated and the control samples.
Dotted line indicates the OD cutoff (ODc) value, which defines biofilm forma-
tion.
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bacteria which were all below the OD cutoff (ODc) defining biofilm
formation, thus revealing a strong anti-biofilm impact of 1018-K6 on
the tested foodborne pathogens. Indeed, further investigations clearly
suggested that a peptide concentration of at least 80 μM was needed to
completely prevent the biofilm formation by all the strains of interest
(data not shown).
4.3. Minimum biofilm eradication concentration (MBEC) determination
An important goal in the treatment of biofilm is to explore the po-
tential application of AMPs in the eradication of biofilms. Indeed, it is
considered that sessile cells are usually more resistant to antimicrobials
with respect to their planktonic counterparts (Høiby, Bjarnsholt,
Givskov, Molin, & Ciofu, 2010), because mature biofilms are sur-
rounded and protected by the components of the extracellular matrix,
such as DNA, polysaccharides, proteins, and others (Flemming &
Wingender, 2010). In this context, the obtained results showed that a
complete S. aureus ATCC 35556 biofilm eradication by 1018-K6 was
reached when the peptide was used at a concentration of 80 μM, even if
a concentration equal to twice (40 μM) its MIC resulted in a 1.7
Log10 CFU/peg reduction of biofilm biomass. Similarly, also MRSA
ATCC 33591 and SA1 biofilms were totally eradicated using the peptide
at 80 μM.
Differently from the previous findings on the ability of 1018-K6 to
inhibit L. monocytogenes biofilm formation (Palmieri et al., 2018), our
study evaluated, for the first time, the eradication activity of this pep-
tide against established biofilms. Therefore, 1018-K6 not only con-
firmed its capability to inhibit biofilm formation, but it also showed a
strong eradicating activity against staphylococcal biofilms.
4.4. Kinetic of action of 1018-K6 against established biofilms of S. aureus
Changing in the amount of biomass during the peptide treatment
were further examined. As reported in Fig. 2, S. aureus MSSA ATCC
35556, MRSA ATCC 33591, and SA1 cell densities in the biofilms were
reduced already after 1min of exposure. Specifically, a complete dis-
ruption in biofilm cell surfaces after 5min was observed in the case of
MSSA ATCC 35556 and SA1, indicating a rapid and substantial killing
efficacy of 1018-K6 (p < 0.0001). On the other hand, although a sig-
nificant reduction of live cells (almost 50%, p=0.0015) in the MRSA
ATCC 33591 biofilms was observed after 5min, the complete biofilm
eradication occurred after 15min of peptide exposure (p < 0.0001).
Finally, no viable cells were detected from 30min to 48 h incubation in
any conditions under investigation.
These results revealed that 1018-K6 was able to remove biofilm cells
within 15min, displaying a remarkable and rapid anti-biofilm activity
against the tested biofilm producer strains. These findings are quite
relevant as it has been found that staphylococci possess genetic in-
formation for the resistance to antimicrobial peptides (Joo & Otto,
2015), since they have developed different molecular mechanisms in-
volved in the prevention of AMP action during both contamination and
infection (Peschel & Sahl, 2006). Such mechanisms – that are controlled
by specific sensor/regulator systems and that include surface charge
alteration, extracellular proteases, exopolymers, and efflux pump pro-
teins (Joo & Otto, 2015) – could also contribute to the different sus-
ceptibility of the tested strains in the response to the peptide.
The results achieved in this study are very impressive in terms of
rate of action of the peptide on existing biofilms. Specifically, AMPs so
far studied showed the ability to eradicate established biofilms after
longer times of exposure (e.g., 6 h of treatment; Laverty, McCloskey,
Gorman, & Gilmore, 2015). Therefore, to the best of our knowledge,
this is the first report concerning the effects of an AMP such as 1018-K6
against established biofilms of pathogenic bacteria within few minutes,
which pointed out a very rapid mechanism of action. For this reason,
we hypothesized that 1018-K6 could kill bacteria in a way that not
necessary involves an intracellular response messenger, as this strategy
would require a time-period longer than minutes to work.
4.5. Structural characterization of 1018-K6
Previous studies have indicated that the interactions of AMPs with
membrane components should result in conformational changes of the
peptide (Palmieri et al., 2016; Pasupuleti, Walse, Svensson, Malmsten,
& Schmidtchen, 2008; Yang et al., 2018; Zelezetsky & Tossi, 2006).
Therefore, CD spectroscopic measurements as function of the peptide
concentration, were applied to examine the secondary structure of
1018-K6 and evaluate the correlation between the 1018-K6 conforma-
tional changes and the antimicrobial/anti-biofilm activities of the
peptide against S. aureus. The results clearly demonstrated that 1018-K6
adopted ɑ-helix/β-sheet mixed conformations in micellar buffer solu-
tion, which remained preserved in the concentration range tested up to
48 h (Fig. 3). Specifically, by using a recently developed web server
called BeStSel, a more accurate estimation of the secondary structure
composition of the 1018-K6 peptide, has been performed from CD
spectra. Indeed, the prediction of β-sheet–rich or α/β-mixed structures
has proven to be difficult and biased due to their spectral variety and
lower spectral amplitudes (Greenfield, 2006) and this is assumed to be
an intrinsic limitation of CD spectroscopy (Khrapunov, 2009). There-
fore, BeStSel improves the accuracy and increases the information re-
lated to the secondary structure prediction better than any other pre-
viously published algorithms (Micsonai et al., 2018). As shown in
Fig. 3, an improvement in the percentage content of β-helix con-
formation, which paralleled to a decrease of the random coil structures,
was observed by increasing the peptide concentration. In Fig. 4, these
structural data are better highlighted and the information obtained by
CD spectroscopy at the extreme of concentrations used (40–80 μM) and
48 h incubation time were compared. The CD spectra obtained at the
two concentrations showed noticeable differences in the relative con-
tent of the secondary structures. In the table included in Fig. 4, the
values of the eight components of secondary structure contents, as
determined with the BeStSel server, were showed and the data were
plotted in a pie chart graphic for an easier display. Thus, the variations
in the far-UV CD signals were attributed to the structural rearrange-
ments in the peptide molecule when analyzed at different concentra-
tions, suggesting that 1018-K6 underwent to conformational changes
with a high tendency to preserve a well-organized structure. Interest-
ingly, the folded condition remained stable at increasing concentrations
with the rate of α-elements substantially unchanged and a conversion of
the total content of β-parallel to antiparallel elements.
Fig. 2. Median and error plot of the eradication activity of 1018-K6 [80 μM]
against 24 h-old Staphylococcus aureus ATCC 35556, methicillin-resistant S.
aureus ATCC 33591, and S. aureus SA1 biofilms at different times of exposure
(whiskers showing 95% CI).
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Results revealed (Supplementary Table 1) that 1018-K6 displayed a
general α/β-mixed structure, which appeared unchangeable both as
function of peptide concentration and incubation time. Therefore,
BeStSel resulted to be more suitable to predict any conformational
changes of peptides in the presence of α/β-mixed folding as for 1018-
K6.
Finally, the CD experiments could suggest that 1018-K6 at in-
creasing concentrations undergoes intermolecular interactions assisted
via a spontaneously self-organization, which arise by the strong ten-
dency to assume β-sheet conformations (Gambaretto, Tonin, Di Bello, &
Dettin, 2008). On this basis, it could be hypothesized that the strongest
anti-biofilm effect exhibited by 1018-K6 against S. aureus at 80 μM was
correlated to a possibly self-assembly process, which can be critical to
affect the S. aureus biofilm stability and its architecture.
4.6. Scanning electron microscopy analysis of 1018-K6 effects on S. aureus
biofilms
Numerous antibacterial peptides kill bacteria predominantly via
membrane permeabilization and subsequent structural disruption, due
to their amphiphilic properties, which render them able to easily insert
into the membranes of bacteria (Batoni, Maisetta, & Esin, 2016;
Brogden, 2005). As shown in Fig. 5, control biofilms (in the absence of
peptide) were uniform and firmly attached, with a continuous, ex-
tensive and interconnected network of cells and exopolymeric matrix
materials. In addition, control pegs resulted covered by multilayered
and three-dimensional structures of sessile cells. In contrast, 1018-K6
exposure induced a significant membrane damage within 16 h treat-
ment. Indeed, detached chunks of floating matrix material and cells in
discontinuous clumps were visible, together with small aggregates of
cells presenting blebbing on the membrane surface (Fig. 6), visibly in-
dicating a significant destabilization and impairment of the cell mem-
brane structure. Therefore, the modification of bacterial morphology
induced by 1018-K6 suggested that the mode of action of the peptide
can be directed to the cell-envelope, rather than to intracellular mes-
sengers involved in biofilm formation.
5. Conclusions
The present study aimed at investigating the bactericidal efficiency
of a novel IDR-1018-derived peptide, named 1018-K6, against plank-
tonic and biofilm-embedded S. aureus ATCC 35556 and MRSA ATCC
33591 cells, as well as against a food isolated enterotoxigenic strain
(SA1). The results achieved demonstrated that 1018-K6 was able to
cause a fast and complete killing of staphylococcal biofilms within the
first 15min, as well as to fully prevent biofilm formation, displaying
also a potent bactericidal activity against planktonic cells. Interestingly,
the antimicrobial and anti-biofilm action of the peptide was observed
not only on the reference strains deriving from ATCC collection, but
also on a wild strain isolated from a food product (i.e., cheese) that
carried the genes encoding for different SEs, indicating efficacy and
potential utility of this peptide in the control of food-related S. aureus
strains.
In addition, after treatment of the reference strain MSSA ATCC
35556 with supra-MIC concentrations of 1018-K6, several distinct signs
of damage to the cell envelope were evident in the SEM micrographs,
such as membrane wrinkling and multiple blebbing. These results could
support a direct cell membrane-affecting mode of action of 1018-K6,
not involving the interaction and inhibition of intracellular messengers
of biofilm. These features represent an advantage for several bio-
technological applications, as the membrane-affecting antimicrobials
exhibit a rapid and broad-spectrum activity and a low propensity to
develop antibiotic-resistance.
Finally, the antimicrobial and anti-biofilm activities, as well as the
reliable modus operandi together with the uncommon stability at dif-
ferent temperature (i.e. 15 and 90 °C) and pH conditions and the scarce
tendency to precipitate in aqueous solutions, make 1018-K6 a good
candidate for industrial uses such as the implementation of “green”
packaging technologies and bio-sanitizing formulations. Further studies
will be necessary to better evaluate 1018-K6 performances both in free-
or bound-form against clinical and environmental isolates of pathogenic
and spoiler bacteria.
Fig. 3. Conformational changes of 1018-K6 as determined by CD spectroscopy.
CD spectra of 1018-K6 at 40 μM (A), 60 μM (B) and 80 μM (C) concentrations in
PBS were recorded in the range 190–260 nm at 25 °C after incubation for 48 h,
in the presence of 3 mM SDS. Structural elements of the peptide predicted using
the BeStSel web server, were shown in pie chart as a percentage of the main
secondary structures.
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doi.org/10.1016/j.foodcont.2019.106815.
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